January 14, 2009
ASKLEP Inc. and XClinical GmbH to jointly exhibit at DIA’s 12th Annual Clinical Data Management Workshop in Tokyo
ASKLEP Inc. (Japan) and XClinical GmbH (Germany) announced today that they will be jointly exhibiting at the DIA Workshop in Tokyo, Japan, January 29th & 30th, 2009. This is their second year the two companies have exhibited together promoting MARVIN, an EDC system for clinical trials. ASKLEP and XClinical have A Strategic Licensing and Development Agreement between them. The Japanese version of MARVIN was launched in July, 2008. The two companies welcome you to come visit their booth at this event.
MARVIN is a robust web-based Electronic Data Capturing (EDC) system designed by investigators which already being used in multiple countries for the past six years.
MARVIN is one of the first EDC systems which is CDISC compliant and CDISC Operational Data Model (ODM) certified system that can transfer data across different EDC systems. CDISC ODM e-protocol technology system can also provide the shortest set-up time in the industry.
About Asklep Inc.
Asklep Inc. (http://www.asklep.co.jp/) founded in 1992, in Tokyo, Japan, is a full service CRO and part of the INTAGE group of companies. ASKLEP services include Clinical Monitoring, Data Management, Biostatistics, Regulatory and Consulting among others. ASKLEP’s Global CRO Network includes Qualitix Clinical Trials (Taiwan), Harrison Clinical Research GmbH (Germany), and ASKA Research (North America).
About XClinical GmbH
XClinical GmbH (http://www.xclinical.com/), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 50+ studies.
For more information on this event, please visit Drug Information Association (DIA): http://www.diahome.org/DIAHome/
